Advantages and Disadvantages of Using Live Vaccines Risks and Control Measures

Acta Veterinaria Scandinavica

Volumn , Issue SUPPL. 90, 1996, Pages 89-100

  Alexandersen, S ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VACCINE;

ANIMAL; ANIMAL DISEASE; BIRD; BIRD DISEASE; CAT; CAT DISEASE; CATTLE; CATTLE DISEASE; DOG; DOG DISEASE; MINK; REVIEW; SWINE; SWINE DISEASE; VIRUS INFECTION;

ANIMALS; BIRD DISEASES; BIRDS; CAT DISEASES; CATS; CATTLE; CATTLE DISEASES; DOG DISEASES; DOGS; MINK; SWINE; SWINE DISEASES; VIRAL VACCINES; VIRUS DISEASES;

EID: 0030330053     PISSN: 0044605X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aubert MFA: Can vaccination validated by the titration of rabies antibodies in serum of cats and dogs be an alternative to quarantine measures. Abstr. Hyg. Comm. Dis. 1993, 68, R1-R22.
2. Bansal GP, Hatfield JA, Dunn FE, Kramer AA, F Brady, Riggin CH, Collett MS, Yoshimoto K, Kajigaya S, Young NS: Candidate recombinant vaccine for human B19 parvovirus. J. Infect. Dis. 1993, 167, 1034-1044.
3. Bloomfield G. PJB(ed): Trends in Veterinary Research & De velopment, 4. Vaccines. Publications Ltd, London, 1990.
4. Brown F, Karger (eds.): Non-Target Effects of Live Vaccines. In: Development in Biological Standardization. Basel. 1995, 84, p. 1-269. Wimmer E (Ed): Cellular Receptors for Animal Viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1994, p. 1-517.
5. Brown F, Karger (eds.): Non-Target Effects of Live Vaccines. In: Development in Biological Standardization. Basel. 1995, 84, p. 1-269. Wimmer E (Ed): Cellular Receptors for Animal Viruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, 1994, p. 1-517.
6. Fenner FJ, Gibbs EPJ, Murphy FA, Rott R, Studdert MJ, White DO (Ed): Veterinary Virology Academic Press, Inc., San Diego & London, 1993, p. 1-666.
7. Fields B., Martin MM & Kamely D (eds): Genetically Altered Viruses and the Environment. Cold Spring Harbor Laboratory Press, Cold Spring Harbor. 1985, p. 1-353.
8. Gibson CA, Schlesinger JJ, Barrett DT: Prospects for a virus non-structural protein as a subunit vaccine. Vaccine, 1989, 6, 7-9.
9. Glosser JW, Vannier P, Doyle KA, Brumko P, Espeseth DA (eds): Risk Assessment for Ve terinary Biologicals. Summaries and Conclusions. Office Internatio nal des Epizooties, Paris, 1995, 1-52.
10. Issel CJ., Horohov DW, Lea DF, Adams Jr WV, Hagius SD, McManus JM, Allison AC, Montelaro RC: Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.. J. Virol. 1992, 66, 3398-3408.
11. Immune Modulation by Infectious Agents. eds. Zschiesche W., p. 1-308. Gustav Fischer Verlag, Jena, 1987.
12. Kimman TG. Risks connected with the use of conventional and genetically engineerd vaccines. Vet.Quart 1992, 14, 110-118.
13. Lehmann R, Franchini M, Aubert A, Wolfensberger C, Cronier J, Lutz H: Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine. J. Am. Vet. Med. Assoc. 1991, 199, 1446-1452.
14. Marx JL. How DNA viruses may cause cancer.. Science, 1989, 243, 1012-1013.
15. McKee T, Whitton JL: Vaccination to prevent persistent viral infection. J. Virol. 1993, 67, 4372-4378.
16. Mims CA (ed): The pathogenesis of infectious disease. Recovery from infection Academic Press, London & New York, 1987, 226-253.
17. Montelaro R, J Ball, P Rwambo & C Issel: Antigenic variation during persistent lentivirus infections and its implications for vaccine development. Adv. Exp. Med. Biol. 1990, 251: 251-272.
18. Morse SS (ed): The Evolutionary Biology of Viruses. Raven press, New York, 1994, 1-341.
19. Oldstone BAJ: Molecular anatomy of viral persistence. Virol. 1991, 65, 6381-6386.
20. Oldstone MBA, Tishon A, Eddleston M, De la Torre JC, McKee T, Whitton JL: Vaccination to prevent persistent viral infection. J. Virorol. 1993, 67, 4372-4378.
21. Osborne EGS, Glosser JW (eds): Risk Assessment forVeterinary Biologicals. In: Scientific and Technical Review Vol 14, No 4. Office International des Epizooties, Paris, 1995, 909-1283.
22. Osterhaus ADME, Weijer K, Siebelink KHJ, Rimmelzwaan GF, Bosch ML: Toward vaccination against feline leukemia virus and feline immunodeficiency virus infections.. J. Am. Vet. Med. Assoc., 1991, 199, 1443-1446.
23. Peters AR (ed): Vaccines for Veterinary Applications. Bu tterworth-Heinemann Ltd, Oxford, 1993 , p.1-343.
24. Swenson SL, J McMillen & HT Hill: Evaluation of the safety and efficacy of a thymidine kinase, inverted repeat, gI, and gpX gene-deleted pseudorabies vaccine. J. Vet. Diagn. Invest. 1993, 5, 341-346.
25. van Oirschot J.T., Vlak JM & Bazin H (eds): European La boratory Without Walls. Re combinant Viral Veterinary Vaccines. EU publications, Brussels, 19 92, p. 1-19.
26. Wilson GS: The Hazards of Immunization, The Athlone Press, London, 1967, 1-313.
27. Wood PR, Willadsen P, Vercoe JE, Hoskinson RM, Demeyer D (eds): CSIRO Australia, Melbourne, 1994, p. 1-207.
28. Woodrow GC & Levine M (eds): New Generation Vaccines. Marcel Dekker Inc., New York & Basel. 1990, 1-951.